AstraZeneca
AZN
#45
Rank
C$406.03 B
Marketcap
C$261.91
Share price
-0.37%
Change (1 day)
19.04%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): C$7.49

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$7.33. In 2024 the company made an earnings per share (EPS) of C$6.22 an increase over its 2023 EPS that were of C$5.26.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$7.4920.52%
2024C$6.2218.23%
2023C$5.2681.13%
2022C$2.90631.03%
2021C$0.40-88.11%
2020C$3.34136.89%
2019C$1.41-39.41%
2018C$2.33-28.27%
2017C$3.24-14.37%
2016C$3.7924.11%
2015C$3.05127.55%
2014C$1.34-51.96%
2013C$2.79-58.95%
2012C$6.80-32.2%
2011C$10.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.25 108.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$10.08 37.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-74.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.13-29.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.52 330.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.83-61.40%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$15.05 105.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.00 36.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.07-44.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.16-29.57%๐Ÿ‡ฌ๐Ÿ‡ง UK